Has Benjamin Schwartz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,841 in general payments to Benjamin Schwartz, MD across 53 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Benjamin Schwartz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Benjamin Schwartz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Benjamin Schwartz, MD

Orthopaedic Surgery · Peabody, MANPI 1124230305

Payments from drug & device makers

$20,841in general payments, 2019–2025

Across 53 payments — averaging $393.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medacta USA, Inc.$19K
Stryker$2K
Conformis, Inc.$152
Sumitomo Pharma America, Inc.$71
Heron Therapeutics, Inc.$63
Maxx Orthopedics, Inc.$60
plus $165 from 6 others

What the payments were for

Consulting fees$6,80033%
Travel & lodging$11,43955%
Food & beverage$2,60212%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medacta USA, Inc.	24	$18,804
Stryker	14	$1,525
Conformis, Inc.	1	$152
Sumitomo Pharma America, Inc.	3	$71
Heron Therapeutics, Inc.	1	$63
Maxx Orthopedics, Inc.	2	$60
Abbott	2	$48
Radius Health, Inc.	1	$31
Smith+Nephew	2	$26
Bioventus LLC	1	$24
Sanofi-aventis U.S. LLC	1	$19
Zimmer Biomet	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,841 in reported general payments places this provider in the 75th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$488,823

Medicare patients

821

Services billed

9,784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	43	$1,171
Pantoprazole Sodium	29	$102
Oxycodone Hcl	36	$96
Tramadol Hcl	25	$47
Meloxicam	33	$44
Dexamethasone	41	$36

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Peabody

Paul TornettaBoston$16.7M
Thomas ThornhillBoston$12M
Stephen MurphyRoxbury Crossing$8M
Andrew FreibergBoston$5.9M
Jon WarnerBoston$5.5M
Wolfgang FitzBoston$3.7M
Young Min KwonBoston$2.8M
Brian KwonWaltham$1.9M
Simon ChaoNorth Easton$1.6M
Scott SigmanNorth Chelmsford$1.4M

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →